Related Experiment Video
Updated: May 6, 2026

Magnetic Resonance Derived Myocardial Strain Assessment Using Feature Tracking
Published on: February 12, 2011
Rate of Change in Cardiac Magnetic Resonance Imaging Measures Is Associated With Death in Duchenne Muscular Dystrophy
Joseph R Starnes1, Meng Xu2, Kristen George-Durrett1
1Division of Cardiology, Department of Pediatrics Vanderbilt University Medical Center Nashville TN USA.
Insights
Cardiovascular disease worsens faster in Duchenne muscular dystrophy patients who die. Tracking changes in ejection fraction and ventricular volumes can identify high-risk individuals and serve as trial outcomes.
Area of Science:
- Cardiology
- Genetics
- Neurology
Background:
- Cardiovascular disease is the primary cause of mortality in Duchenne muscular dystrophy (DMD).
- Early identification of patients at high risk for mortality is crucial for timely intervention and intensive management.
- Identifying predictive markers can establish surrogate outcomes for clinical trials in DMD.
Purpose of the Study:
- To investigate cardiac magnetic resonance imaging (CMR) parameters that predict mortality in Duchenne muscular dystrophy patients.
- To identify specific rates of change in cardiac function and structure associated with increased mortality risk.
- To evaluate the potential of these changes as surrogate endpoints in therapeutic trials.
Main Methods:
- Prospective enrollment of Duchenne muscular dystrophy subjects in observational studies.
- Utilized generalized least squares models to compare CMR measurements between deceased and surviving participants.
- Analyzed data from 63 participants with multiple CMR assessments over a median follow-up of 5 years.
Main Results:
- Twelve participants (19.1%) died during the follow-up period.
- Deceased subjects exhibited a faster rate of decline in left ventricular ejection fraction (P<0.0001).
- Increased rates of left ventricular end-diastolic (P=0.0132) and systolic (P<0.0001) volumes were observed in deceased subjects.
- Faster progression of mid-circumferential strain was noted in deceased individuals (P=0.049), but global circumferential strain showed no significant difference.
- Rates of change in late gadolinium enhancement, base T1, and mid T1 did not differ between the groups.
Conclusions:
- The rate of change in left ventricular ejection fraction, mid-circumferential strain, and ventricular volumes are significantly associated with mortality in Duchenne muscular dystrophy.
- Intensified medical therapies aimed at slowing disease progression may reduce mortality rates in DMD patients.
- A reduced rate of cardiac progression could serve as a valid surrogate outcome measure in clinical trials for Duchenne muscular dystrophy.
Background:
Cardiovascular disease is the leading cause of death among patients with Duchenne muscular dystrophy (DMD). Identifying patients at risk of early death could allow for increased monitoring and more intensive therapy. Measures that associate with death could serve as surrogate outcomes in clinical trials.
Methods And Results:
Duchenne muscular dystrophy subjects prospectively enrolled in observational studies were included. Models using generalized least squares were used to assess the difference of cardiac magnetic resonance measurements between deceased and alive subjects. A total of 63 participants underwent multiple cardiac magnetic resonance imaging and were included in the analyses. Twelve subjects (19.1%) died over a median follow-up of 5 years (interquartile range, 3.1-7.0). Rate of decline in left ventricular ejection fraction was faster in deceased than alive subjects (P<0.0001). Rate of increase in indexed left ventricular end-diastolic (P=0.0132) and systolic (P<0.0001) volumes were higher in deceased subjects. Faster worsening in midcircumferential strain was seen in deceased subjects (P=0.049) while no difference in global circumferential strain was seen. The rate of increase in late gadolinium enhancement, base T1, and mid T1 did not differ between groups.
Conclusions:
Duchenne muscular dystrophy death is associated with the rate of change in left ventricular ejection fraction, midcircumferential strain, and ventricular volumes. Aggressive medical therapy to decrease the rate of progression may improve the mortality rate in this population. A decrease in the rate of progression may serve as a valid surrogate outcome for therapeutic trials.
More Related Videos
12:24Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
09:18Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy